Does DEUCRAVACITINIB Cause Herpes zoster? 23 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Herpes zoster have been filed in association with DEUCRAVACITINIB (SOTYKTU). This represents 1.0% of all adverse event reports for DEUCRAVACITINIB.
23
Reports of Herpes zoster with DEUCRAVACITINIB
1.0%
of all DEUCRAVACITINIB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Herpes zoster From DEUCRAVACITINIB?
Of the 23 reports, 1 (4.3%) required hospitalization.
Is Herpes zoster Listed in the Official Label?
Yes, Herpes zoster is listed as a known adverse reaction in the official FDA drug label for DEUCRAVACITINIB.
What Other Side Effects Does DEUCRAVACITINIB Cause?
Drug ineffective (228)
Acne (225)
Pruritus (187)
Rash (175)
Erythema (124)
Psoriasis (122)
Off label use (101)
Adverse event (74)
Mouth ulceration (72)
Folliculitis (65)
What Other Drugs Cause Herpes zoster?
ADALIMUMAB (3,783)
TOFACITINIB (3,575)
ETANERCEPT (3,129)
METHOTREXATE (2,589)
RITUXIMAB (2,228)
INFLIXIMAB (2,081)
LENALIDOMIDE (1,762)
TOCILIZUMAB (1,676)
OCRELIZUMAB (1,433)
ABATACEPT (1,395)
Which DEUCRAVACITINIB Alternatives Have Lower Herpes zoster Risk?
DEUCRAVACITINIB vs DEUTETRABENAZINE
DEUCRAVACITINIB vs DEUTIVACAFTOR\TEZACAFTOR\VANZACAFTOR
DEUCRAVACITINIB vs DEVICE
DEUCRAVACITINIB vs DEXAMETHASONE
DEUCRAVACITINIB vs DEXAMETHASONE\DEXAMETHASONE